English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$C4 Therapeutics (CCCC.US)$ C4 Therapeutics Has Entered Into A License Agreement With Merck KGaA, To Exclusively Discover Two Targeted Protein Degraders Against Critical Oncogenic Proteins, C4 Therapeutics Will Receive $16M As Upfront And Is Eligible Of Up $740M In Milestone Payment
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
22K Views
Comment
Sign in to post a comment
    5048
    Followers
    24
    Following
    72K
    Visitors
    Follow